G Fredj

614 total citations
40 papers, 483 citations indexed

About

G Fredj is a scholar working on Pharmacology, Surgery and Oncology. According to data from OpenAlex, G Fredj has authored 40 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Surgery and 6 papers in Oncology. Recurrent topics in G Fredj's work include Renal Transplantation Outcomes and Treatments (5 papers), Analytical Chemistry and Chromatography (5 papers) and Analytical Methods in Pharmaceuticals (5 papers). G Fredj is often cited by papers focused on Renal Transplantation Outcomes and Treatments (5 papers), Analytical Chemistry and Chromatography (5 papers) and Analytical Methods in Pharmaceuticals (5 papers). G Fredj collaborates with scholars based in France, Russia and South Korea. G Fredj's co-authors include J.L. Misset, G Mathé, Gilles Peytavin, E. Chenu, S. Brienza, C Bourut, Masazumi Eriguchi, Yoshinori Kidani, M. Micoud and Henri Bismuth and has published in prestigious journals such as Hepatology, Clinical Infectious Diseases and International Journal of Pharmaceutics.

In The Last Decade

G Fredj

38 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Fredj France 11 180 84 80 68 55 40 483
Dulal C. Chatterji United States 14 140 0.8× 131 1.6× 49 0.6× 42 0.6× 41 0.7× 31 563
Douglas H. Sandberg United States 13 186 1.0× 99 1.2× 124 1.6× 55 0.8× 84 1.5× 30 639
Martin Czejka Austria 15 245 1.4× 158 1.9× 44 0.6× 80 1.2× 27 0.5× 70 739
A. E. Cowen Australia 15 213 1.2× 65 0.8× 191 2.4× 29 0.4× 77 1.4× 33 566
Kiumars Vadiei United States 16 90 0.5× 118 1.4× 55 0.7× 62 0.9× 40 0.7× 26 588
A J Pesce United States 15 51 0.3× 155 1.8× 100 1.3× 41 0.6× 50 0.9× 30 691
Marc Galtier France 11 132 0.7× 92 1.1× 25 0.3× 92 1.4× 33 0.6× 19 470
E. Abisch Switzerland 9 85 0.5× 75 0.9× 108 1.4× 71 1.0× 57 1.0× 13 525
K. S. Cathcart United States 9 157 0.9× 206 2.5× 33 0.4× 130 1.9× 46 0.8× 9 441
G. Bastian France 12 237 1.3× 154 1.8× 36 0.5× 28 0.4× 26 0.5× 39 403

Countries citing papers authored by G Fredj

Since Specialization
Citations

This map shows the geographic impact of G Fredj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Fredj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Fredj more than expected).

Fields of papers citing papers by G Fredj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Fredj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Fredj. The network helps show where G Fredj may publish in the future.

Co-authorship network of co-authors of G Fredj

This figure shows the co-authorship network connecting the top 25 collaborators of G Fredj. A scholar is included among the top collaborators of G Fredj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Fredj. G Fredj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonhomme‐Faivre, Laurence, et al.. (1998). Study of Human Neurovegetative and Hematologic Effects of Environmental Low-Frequency (50-Hz) Electromagnetic Fields Produced by Transformers. Archives of Environmental Health An International Journal. 53(2). 87–92. 29 indexed citations
2.
Bézie, Yvonnick, et al.. (1997). Study of the correlation between MEIA and ELISA methods for FK 506 determination in liver transplant recipients. Journal of Clinical Pharmacy and Therapeutics. 22(2). 135–140. 4 indexed citations
3.
Massari, Claire, et al.. (1995). HPLC determination of the stability of retinoic acid in ovule formulations for the treatment of cervical dysplasia related to papillomavirus. International Journal of Pharmaceutics. 115(2). 235–240. 3 indexed citations
4.
Lemoine, Antoinette, Daniel Azoulay, Ashley R. Dennison, et al.. (1994). FK 506 renal toxicity and lack of detectable cytochrome P-450 3A in the liver graft of a patient undergoing liver transplantation. Hepatology. 20(6). 1472–1477. 12 indexed citations
5.
Bonhomme‐Faivre, Laurence, et al.. (1994). Treatment of AIDS-associated Kaposi’s sarcoma with oral tretinoin. American Journal of Health-System Pharmacy. 51(19). 2417–2419. 8 indexed citations
6.
Orbach‐Arbouys, S., et al.. (1993). Macrophage activity may be modified in vivo by galenical excipients. International Journal of Pharmaceutics. 96(1-3). R7–R10. 1 indexed citations
7.
Lemoine, Antoinette, Daniel Azoulay, Ashley R. Dennison, et al.. (1993). RELATIONSHIP BETWEEN GRAFT CYTOCHROME P-450 3A CONTENT AND EARLY MORBIDITY AFTER LIVER TRANSPLANTATION1. Transplantation. 56(6). 1410–1414. 19 indexed citations
8.
Fredj, G, et al.. (1993). [Comparison of tacrine hepatotoxicity in patients with Alzheimer disease or AIDS].. PubMed. 47(3). 245–7. 1 indexed citations
9.
Azoulay, Daniel, Antoinette Lemoine, R. Adam, et al.. (1993). Lidocaine metabolite formation in the liver donor as a predictive test for the safe and efficient introduction of cyclosporine in the recipient.. PubMed. 25(3). 2275–8. 7 indexed citations
10.
Mathieu, M.C., et al.. (1992). Intratumor treatment off C3H mouse mammary carcinoma with 5-fluorouracil adsorbed on activated charcoal particles. Anti-Cancer Drugs. 3(3). 261–266. 5 indexed citations
11.
Mathieu, Marie, et al.. (1992). Charcoal tattooing of mammary carcinoma in mice. International Journal of Pharmaceutics. 80(1-3). 271–275. 4 indexed citations
12.
Fredj, G, et al.. (1992). Open trial of tacrine therapy in 70 HIV-infected patients.. PubMed. 30(9). 313–6. 3 indexed citations
13.
Fredj, G, et al.. (1989). Tetrahydroaminoacridine in HIV infections. The THA Study Group.. PubMed. 27(8). 408–10. 1 indexed citations
14.
Fredj, G, et al.. (1989). [Pharmacokinetic study of pyrazinamide and pyrazinoic acid in subjects with normal renal function and patients with renal failure].. PubMed. 44(1). 1–4. 2 indexed citations
15.
Adam, René, et al.. (1989). Liver preservation: 31P and 13C NMR spectroscopic assessment of liver energy and metabolism after cold storage in Collins, Marshall, Ringer's lactate, UW and modified UW solutions.. PubMed. 21(1 Pt 2). 1327–9. 10 indexed citations
16.
Paillet, Matthieu, et al.. (1986). Rapid determination of clofibric acid in human plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 375. 179–183. 6 indexed citations
17.
Fredj, G, et al.. (1986). [Topical digestive drugs with a clay base. Influence on the absorption of cimetidine].. PubMed. 41(1). 23–5. 2 indexed citations
18.
Colin, J. N., et al.. (1986). Kinetics of allopurinol and oxipurinol after chronic oral administration. Interaction with benzbromarone. European Journal of Clinical Pharmacology. 31(1). 53–58. 15 indexed citations
19.
Fredj, G, et al.. (1983). [Bioavailability of oral and rectal indomethacin].. PubMed. 38(2). 105–8. 1 indexed citations
20.
Fredj, G, et al.. (1979). Action of Tiadenol and Clofibrate on Biliary Excretions of Cholesterol and Bile Salts in Rats. Digestion. 19(4). 228–236. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026